Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Food Funct ; 15(11): 5797-5812, 2024 Jun 04.
Artículo en Inglés | MEDLINE | ID: mdl-38747250

RESUMEN

Ulcerative colitis (UC) is a common chronic inflammatory disease that causes serious harm to human health. Probiotics have the effect of improving UC. This study evaluated the preventative potential of water-in-oil-in-water (W1/O/W2) emulsions containing both probiotics and fish oil on UC and associated anxiety-like behavior using a mice model. UC model was established in mice by administering dextran sulfate sodium salt (DSS). Free probiotics, probiotic-loaded emulsions, or fish oil and probiotic co-loaded emulsions were then orally administered to the mice. Various bioassays, histological studies, 16s rDNA gene sequencing, and behavioral experiments were conducted to assess changes in the intestinal environment, microbiota, and anxiety-like behavior of the mice. The fish oil and probiotic co-loaded emulsions significantly reduced the inflammatory response by enhancing tight junction protein secretion (ZO-1, Occludin, and Claudin-1), inhibiting pro-inflammatory factors (TNF-α, and IL-1ß), and promoting short-chain fatty acids (SCFAs) production. These emulsions also modified the gut microbiota by promoting beneficial bacteria and suppressing pathogenic bacteria, thereby restoring a balanced gut microbiota. Notably, the emulsions containing both probiotics and fish oil also ameliorated anxiety-like behavior in the mice. The co-delivery of probiotics and fish oil using W1/O/W2 emulsions has shown significant promise in relieving UC and its associated anxiety-like behavior. These findings provide novel insights into the development of advanced therapeutic strategies for treating UC.


Asunto(s)
Colitis Ulcerosa , Emulsiones , Aceites de Pescado , Microbioma Gastrointestinal , Probióticos , Animales , Colitis Ulcerosa/tratamiento farmacológico , Colitis Ulcerosa/inducido químicamente , Emulsiones/química , Probióticos/farmacología , Aceites de Pescado/farmacología , Ratones , Microbioma Gastrointestinal/efectos de los fármacos , Masculino , Modelos Animales de Enfermedad , Ratones Endogámicos C57BL , Agua , Sulfato de Dextran/efectos adversos , Humanos
2.
Adv Colloid Interface Sci ; 320: 102999, 2023 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-37783067

RESUMEN

Research on the design, fabrication, and application of double network (DN) hydrogels, assembled from pairs of polymers, has grown recently due to their unique structural, physicochemical, and functional properties. DN hydrogels can be designed to exhibit a broader range of functional attributes than single network (SN) ones, which extends their applications in various fields. There has been strong interest in the development of biopolymer DN hydrogels because of their environmental, sustainability, and safety benefits. However, there is limited knowledge on the formation and application of these novel materials. This article reviews the principles underlying the design and fabrication of hydrogels using different crosslinking approaches, including covalent and/or non-covalent bonding, and the formation mechanisms, network structures, and functional attributes of different DN hydrogels. The impact of polymer composition, structural organization, and bonding on the mechanical and functional properties of DN hydrogels is reviewed. Potential applications of these hydrogels are highlighted, including in tissue engineering, biomedicines, and foods. The functional attributes of DN hydrogels can be tailored to each of these applications by careful selection of the biopolymers and crosslinking mechanisms used to assemble them. Finally, areas where further research are needed to overcome the current limitations of DN hydrogels are highlighted.


Asunto(s)
Materiales Biocompatibles , Hidrogeles , Materiales Biocompatibles/química , Hidrogeles/química , Ingeniería de Tejidos , Polímeros
3.
ACS Appl Mater Interfaces ; 15(14): 18166-18181, 2023 Apr 12.
Artículo en Inglés | MEDLINE | ID: mdl-36893425

RESUMEN

Curcumin has been reported to exhibit free radical antioxidant, anti-inflammatory, and anticancer activities, which are beneficial for nutraceutical applications. However, its application for this purpose is limited by its poor water solubility, stability, and bioavailability. These problems can be overcome using food-grade colloidal particles that encapsulate, protect, and deliver curcumin. These colloidal particles can be assembled from structure-forming food components that may also exhibit protective effects, such as proteins, polysaccharides, and polyphenols. In this study, lactoferrin (LF), (-)-epigallocatechin gallate (EGCG), and hyaluronic acid (HA) were used to fabricate composite nanoparticles using a simple pH-shift method. We showed that curcumin could be successfully loaded into these LF-EGCG-HA nanoparticles (d = 145 nm). The encapsulation efficiency (86%) and loading capacity (5.8%) of curcumin within these nanoparticles were relatively high. Encapsulation improved the thermal, light, and storage stabilities of the curcumin. Moreover, the curcumin-loaded nanoparticles exhibited good redispersibility after dehydration. The in vitro digestion properties, cellular uptake, and anticancer effects of the curcumin-loaded nanoparticles were then explored. Compared to free curcumin, the bioaccessibility and cellular uptake of the curcumin were significantly improved after encapsulation in the nanoparticles. Furthermore, the nanoparticles significantly promoted the apoptosis of colorectal cancer cells. This study suggests that food-grade biopolymer nanoparticles can be used to improve the bioavailability and bioactivity of an important nutraceutical.


Asunto(s)
Curcumina , Nanopartículas , Curcumina/farmacología , Curcumina/metabolismo , Lactoferrina , Antioxidantes/farmacología , Apoptosis , Tamaño de la Partícula , Portadores de Fármacos
4.
Adv Colloid Interface Sci ; 309: 102781, 2022 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-36209686

RESUMEN

Adequate intake of live probiotics can provide benefits to human health and wellbeing. However, free probiotics tend to lose their viability during the production, storage, and distribution of foods, as well as during their passage through the human gastrointestinal tract. A well-designed probiotic encapsulation system can enhance the viability of probiotics in foods and within the gastrointestinal tract, thereby ensuring more live bacteria reach the colon in an active form. This review summarizes the design of encapsulated probiotics and focuses on recent progress on the development of co-encapsulation systems containing mixed probiotics, mixtures of probiotics and prebiotics ("synbiotics"), or mixtures of probiotics and nutraceuticals ("nutrabiotics"). It then discusses the application of these co-encapsulation systems in functional foods, and highlights their potential benefits for human health, including regulating intestinal flora balance, safeguarding intestinal barrier integrity, maintaining immune homeostasis, and regulating blood glucose levels. Finally, challenges facing the large-scale commercialization of probiotic-loaded functional foods are discussed and suggestions for improving their performance are highlighted.


Asunto(s)
Probióticos , Simbióticos , Humanos , Glucemia , Prebióticos , Tracto Gastrointestinal/microbiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA